Norway - Hospital Discharges for Malignant Neoplasm of Prostate
Since 2014, Norway Hospital Discharges for Malignant Neoplasm of Prostate decreased by 1.2% year on year. At 3,783 Hospital Discharges in 2019, the country was number 22 among other countries in Hospital Discharges for Malignant Neoplasm of Prostate. Norway is overtaken by Chile, which was ranked number 21 with 4,128 Hospital Discharges and is followed by Denmark with 2,700 Hospital Discharges. Germany, France and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. South Korea recorded the best 5 years average growth at +9.5% per year, while Ireland was the worst growing country at -5.7% per year.
Loading...
| Date | Units (Hospital Discharges) |
|---|---|
| 2019 | 3,783.00 |
| 2018 | 3,449.00 |
| 2017 | 3,680.00 |
| 2016 | 3,867.00 |
| 2015 | 4,280.00 |
Download all data from 1990 to 2019
How does Norway rank in Hospital Discharges for Malignant Neoplasm of Prostate?
| # | 33 Countries | Units (Hospital Discharges) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Japan
|
184,700 | 2017 | NA | NA | View data | |
| 2 |
#2
Germany
|
106,773 | 2019 | +0.7 % | +3.1 % | View data | |
| 21 |
#21
Chile
|
4,128 | 2019 | +0.3 % | +4.7 % | View data | |
| 22 |
#22
Norway
|
3,783 | 2019 | +9.7 % | -1.2 % | View data | |
| 23 |
#23
Denmark
|
2,700 | 2019 | -2.3 % | -2.1 % | View data | |